Rovira, I, Montemayor, E, Gil-Alonso, S, Miranda-Cadena, K, Sanchez-Reus, F, Quindos, G, Eraso, E, Jauregizar, N. A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin. ACS Omega. 2026; 11(5)DOI:10.1021/acsomega.5c10111. PMID:41696345. IF:4.300(Q2/4D).

Pérez, MAC, Grillo, S, Rombauts, A, Martinez, MAR, Falcó-Roget, A, Albasanz-Puig, A, Viñado-Pérez, B, Fernández-Hidalgo, N, Camps-Relats, L, Bergas, A, Laporte-Amargos, J, López-Contreras, J, Escolà-Vergé, L. Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2026; 67(2)DOI:10.1016/j.ijantimicag.2025.107706. PMID:41456670. IF:4.600(Q1/2D).

Piriz-Marabajan, M, Rombauts, A, Roch-Villaverde, N, Cortes-Palacios, AP, Fernandez-Piqueras, E, Serrano-Condal, S, Taltavull-Menendez, M, Grillo, S, Simonetti, AF, Duch, P, Pomar-Solchaga, V, Escolà-Vergé, L, Lopez-Contreras, J. Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study. JOURNAL OF HOSPITAL INFECTION. 2026; 167DOI:10.1016/j.jhin.2025.09.009. PMID:41075840. IF:3.100(Q1/3D).

Monje, A, Escolà-Vergé, L, Rivera, A, Herrera, S, Plaza, A, Duch-Llorach, P, Pomar, V, Roch, N, Rouras, L, Lopez-Contreras, J, Ramos, JR. Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit. Antibiotics-Basel. 2025; 14(12)DOI:10.3390/antibiotics14121261. PMID:41463763. IF:4.600(Q1/2D).

Lazzari, R, Cano, MB, Martínez, AR, Bueno, MR, Rovira, MC, Campmany, MP. Vibrio fluvialis cholangitis with bacteremia and refractory septic shock: a case report and review of the literature. INFECTION. 2025; 53(6)DOI:10.1007/s15010-025-02535-7. PMID:40377851. IF:3.600(Q2/3D).

Casares, LD, Pereiro, JE, Fernández, MTT, García, XC, Millet, JP, Solchaga, VP, Elorza, EN, García, JT, de Santiago, AD, Márquez, RL, Gallardo, JFM, Galán, VG, Alonso, MM, Brusola, AG, Rey, RR, García, LA, Herrero, FS, Serrano, RG, Fullola, MG, Díez, MT, Zanon, TT, Portero, MF, García, PA, Lopez, AMS, Aznar, ML, Camprecios, JM, Saborit, N, Montalvá, AS. Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol. Bmj Open Respiratory Research. 2025; 12(1)DOI:10.1136/bmjresp-2024-002475. PMID:41360613. IF:3.400(Q2/3D).

Martínez-Ysasis, Y, Simonetti, AF, Navarro, F. Megaprosthesis Infection by Bacteroides fragilis in a Patient With Ewing's Sarcoma: A Case Report and Literature Review. Clinical Case Reports. 2025; 13(2)DOI:10.1002/ccr3.70185. PMID:39931721. IF:(Q/D).

Mostaza, JM, Suarez, C, Cepeda, JM, Manzano, L, Sanchez, D, Mascaró J., Maestre Peiro, Ana. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation. BMC Cardiovascular Disorders. 2021; 21(1)DOI:10.1186/s12872-021-02019-0. PMID:34372782. IF:2.174(Q4/8D).